Form D — Rezo Therapeutics, Inc.
0001853446-25-000004 · filed Aug 18, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $80,129,936
- Total sold
- $68,066,039
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Rezo Therapeutics, Inc.
- CIK
- 1956559
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO, CA 94158 - Phone
- 415-310-4524
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Derek Hicks · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
-
Nevan Krogan · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
-
Vineeta Agarwala · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
Tiba Aynechi · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
Norbert Bischofberger · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
Simeon George · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
George Scangos · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
Jennifer Chang · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗